in a prospective , randomized trial cancer and leukemia group b ( calgb ) evaluated caf chemotherapy ( cyclophosphamide + doxorubicin + 5-fluorouracil [ 5-fu ] ) v caf plus tamoxifen ( tcaf ) in advanced breast cancer .
C0054427
cyclophosphamide
C0016360
5-fu